13F Filings for Crestline Management, LP (CIK: 1536054)

View the most recent portfolio holdings disclosed by Crestline Management, LP in their 13F filing.

HoldingSharesValuePortfolio PercentChange StatusChange Amount
DNLI - DENALI THERAPEUTICS INC(Class: COM)3.86M $54.01M 86.33%Decreased 300K (7.0%, $2.55M)
SANA - SANA BIOTECHNOLOGY INC(Class: COM)2.42M $6.61M 10.56%Decreased 370K (13.0%, $1.92M)
EGHT - 8X8 INC NEW(Class: COM)990.58K $1.94M 3.10%Unchanged